ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager

ADC Therapeutics SA

NYSE:ADCT

Watchlist

Price: 3.21 USD 3.55% Market Closed

Market Cap: 308.9m USD

Have any thoughts about
ADC Therapeutics SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 3.21 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

ADCT Alert

ADC Therapeutics SA

3.21

+0.11 (+3.55%)

52 Week Range	0.4681 5.29
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

ADC Therapeutics SA

What unique competitive advantages
does ADC Therapeutics SA hold over its rivals?

What risks and challenges
does ADC Therapeutics SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of ADC Therapeutics SA.

What unique competitive advantages
does ADC Therapeutics SA hold over its rivals?

What risks and challenges
does ADC Therapeutics SA face in the near future?

Has there been any significant insider trading activity
in ADC Therapeutics SA recently?

Summarize the latest earnings call
of ADC Therapeutics SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ADC Therapeutics SA.

Provide P/S
for ADC Therapeutics SA.

Provide P/E
for ADC Therapeutics SA.

Provide P/OCF
for ADC Therapeutics SA.

Provide P/FCFE
for ADC Therapeutics SA.

Provide P/B
for ADC Therapeutics SA.

Provide EV/S
for ADC Therapeutics SA.

Provide EV/GP
for ADC Therapeutics SA.

Provide EV/EBITDA
for ADC Therapeutics SA.

Provide EV/EBIT
for ADC Therapeutics SA.

Provide EV/OCF
for ADC Therapeutics SA.

Provide EV/FCFF
for ADC Therapeutics SA.

Provide EV/IC
for ADC Therapeutics SA.

Show me price targets
for ADC Therapeutics SA made by professional analysts.

What are the Revenue projections
for ADC Therapeutics SA?

How accurate were the past Revenue estimates
for ADC Therapeutics SA?

What are the Net Income projections
for ADC Therapeutics SA?

How accurate were the past Net Income estimates
for ADC Therapeutics SA?

What are the EPS projections
for ADC Therapeutics SA?

How accurate were the past EPS estimates
for ADC Therapeutics SA?

What are the EBIT projections
for ADC Therapeutics SA?

How accurate were the past EBIT estimates
for ADC Therapeutics SA?

Compare the revenue forecasts
for ADC Therapeutics SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ADC Therapeutics SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ADC Therapeutics SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of ADC Therapeutics SA compared to its peers.

Compare the P/E ratios
of ADC Therapeutics SA against its peers.

Discuss the investment returns and shareholder value creation
comparing ADC Therapeutics SA with its peers.

Analyze the financial leverage
of ADC Therapeutics SA compared to its main competitors.

Show all profitability ratios
for ADC Therapeutics SA.

Provide ROE
for ADC Therapeutics SA.

Provide ROA
for ADC Therapeutics SA.

Provide ROIC
for ADC Therapeutics SA.

Provide ROCE
for ADC Therapeutics SA.

Provide Gross Margin
for ADC Therapeutics SA.

Provide Operating Margin
for ADC Therapeutics SA.

Provide Net Margin
for ADC Therapeutics SA.

Provide FCF Margin
for ADC Therapeutics SA.

Show all solvency ratios
for ADC Therapeutics SA.

Provide D/E Ratio
for ADC Therapeutics SA.

Provide D/A Ratio
for ADC Therapeutics SA.

Provide Interest Coverage Ratio
for ADC Therapeutics SA.

Provide Altman Z-Score Ratio
for ADC Therapeutics SA.

Provide Quick Ratio
for ADC Therapeutics SA.

Provide Current Ratio
for ADC Therapeutics SA.

Provide Cash Ratio
for ADC Therapeutics SA.

What is the historical Revenue growth
over the last 5 years for ADC Therapeutics SA?

What is the historical Net Income growth
over the last 5 years for ADC Therapeutics SA?

What is the current Free Cash Flow
of ADC Therapeutics SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for ADC Therapeutics SA.

ADCT

Income Statement

Income from Continuing Operations

ADC Therapeutics SA
Income from Continuing Operations

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

ADC Therapeutics SA
Income from Continuing Operations Peer Comparison

Comparables:

ACIU

CRSP

BSLN

IDIA

KURN

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

	Income from Continuing Operations	CAGR 3Y	CAGR 5Y	CAGR 10Y
ADC Therapeutics SA NYSE:ADCT	Income from Continuing Operations -$234.5m	CAGR 3-Years 2%	CAGR 5-Years -14%	CAGR 10-Years N/A
AC Immune SA NASDAQ:ACIU	Income from Continuing Operations -CHf54.6m	CAGR 3-Years 8%	CAGR 5-Years N/A	CAGR 10-Years N/A
CRISPR Therapeutics AG NASDAQ:CRSP	Income from Continuing Operations -$265.9m	CAGR 3-Years N/A	CAGR 5-Years -6%	CAGR 10-Years N/A
Basilea Pharmaceutica AG SIX:BSLN	Income from Continuing Operations -CHf652k	CAGR 3-Years 76%	CAGR 5-Years 51%	CAGR 10-Years 33%
Idorsia Ltd SIX:IDIA	Income from Continuing Operations -CHf297.9m	CAGR 3-Years 13%	CAGR 5-Years 5%	CAGR 10-Years N/A
Kuros Biosciences AG SIX:KURN	Income from Continuing Operations -CHf8.9m	CAGR 3-Years -15%	CAGR 5-Years 5%	CAGR 10-Years N/A

What is ADC Therapeutics SA's Income from Continuing Operations?

Income from Continuing Operations
-234.5m USD

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Income from Continuing Operations amounts to -234.5m USD.

What is ADC Therapeutics SA's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 5Y
-14%

Over the last year, the Income from Continuing Operations growth was -51%. The average annual Income from Continuing Operations growth rates for ADC Therapeutics SA have been 2% over the past three years , -14% over the past five years .

ADC Therapeutics SA
NYSE:ADCT

ADC Therapeutics SA
Income from Continuing Operations

ADC Therapeutics SA
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

See Also

What is ADC Therapeutics SA's Income from Continuing Operations?

Income from Continuing Operations
-234.5m USD

What is ADC Therapeutics SA's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 5Y
-14%

Company

Help

Tools

Stocks

ADC Therapeutics SA NYSE:ADCT

ADC Therapeutics SA Income from Continuing Operations

ADC Therapeutics SA Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis Latest Figures & CAGR of Competitors

See Also

What is ADC Therapeutics SA's Income from Continuing Operations? Income from Continuing Operations -234.5m USD

What is ADC Therapeutics SA's Income from Continuing Operations growth rate? Income from Continuing Operations CAGR 5Y -14%

Company

Help

Tools

Stocks

ADC Therapeutics SA
NYSE:ADCT

ADC Therapeutics SA
Income from Continuing Operations

ADC Therapeutics SA
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

What is ADC Therapeutics SA's Income from Continuing Operations?

Income from Continuing Operations
-234.5m USD

What is ADC Therapeutics SA's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 5Y
-14%